Lunray Medical Secures Tens of Millions RMB in Series A Funding Led by Share Investment to Build Premier Imaging Expert Network

VCBeat (WeChat ID: vcbeat) recently learned that Lunqin (Shanghai) Medical Technology Co., Ltd. (“Rontgen Medical”) announced it had secured tens of millions of RMB in its first round of financing from Fenxiang Investment.

Rontgen, established in 2016, specializes in intelligent imaging healthcare services, hospital department operational management, training of imaging medicine professionals, and domestic and international academic exchanges and collaborations. It is committed to becoming China’s largest, most professional, and most influential group of radiologists and medical imaging technology company.

The company has assembled a team of leading experts in medical imaging and related fields from across China. This expert team has undertaken multiple national-level research projects and spearheaded the development of industry standards for the service systems of third-party medical imaging centers. Professor Feng Xiaoyuan, the Chairman, previously held key positions including Vice President of Fudan University, Party Secretary and Vice President of Huashan Hospital, and Chairman of the Chinese Society of Radiology under the Chinese Medical Association. He was also the first Asian member of the International Healthcare Strategy Committee of the International Health Group (IHG).

The lead investor in this round, Fenxiang Investment, is a renowned venture capital firm in the healthcare sector. It has backed numerous companies that have successfully gone public, including BGI Genomics, Meinian Onehealth Healthcare, and Buchang Pharmaceuticals. Additionally, portfolio companies such as Genetron Health, iCarbonX, Janus Bioprinting, Medprin Regenerative Medical Technologies, and Zhang Qiang Doctor Group hold leading positions in their respective niche markets.

The reason for choosing Rontgen is that investors are optimistic about the huge and broad development prospects of China's medical imaging industry, as well as Rontgen's leading professional strength in its expert team and its ability to integrate scarce medical resources.

In recent years, the government has actively encouraged, introduced, and supported social capital in establishing third-party independent imaging diagnostic service institutions, while also allowing physicians to practice at multiple sites and promoting the development of medical information sharing service platforms.

Feng Xiaoyuan stated that Rontgen was established by leveraging the right timing, favorable conditions, and strong teamwork. Its original aspiration is to redefine the social value of physicians and reshape healthcare service models, making the advanced diagnostic and therapeutic capabilities of top-tier medical imaging experts accessible to and empowering for various medical institutions and young doctors across China, thereby promoting a more balanced and adequate allocation and utilization of medical resources.